| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3328467 | Acta Haematologica Polonica | 2012 | 6 Pages |
Abstract
primary myelofibrosis (pmf) belongs to chronic myeloid neoplasms with the worst prognosis in terms of survival and quality of life. This article summarizes current knowledge on molecular and cytogenetic factors related with pmf, presents various stratifications, clinical systems and therapeutic options.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Tomasz (Prof. dr hab.),